186 related articles for article (PubMed ID: 21034452)
1. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
[TBL] [Abstract][Full Text] [Related]
2. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
3. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
[TBL] [Abstract][Full Text] [Related]
5. ADAM12s as a first-trimester screening marker of trisomy.
Wortelboer EJ; Linskens IH; Koster MP; Stoutenbeek P; Cuckle H; Blankenstein MA; Visser GH; van Vugt JM; Schielen PC
Prenat Diagn; 2009 Sep; 29(9):866-9. PubMed ID: 19544290
[TBL] [Abstract][Full Text] [Related]
6. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
Pihl K; Larsen T; Krebs L; Christiansen M
Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester.
Liao C; Han J; Sahota D; Li DZ; Sun Q; Lin L; Zhou JY; Yang X; Pan M; Huang YN
J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1305-9. PubMed ID: 20230315
[TBL] [Abstract][Full Text] [Related]
8. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
10. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
12. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
13. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
14. Aneuploidy screening in the first trimester.
Spencer K
Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):18-32. PubMed ID: 17290444
[TBL] [Abstract][Full Text] [Related]
15. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Wang M; Lu S; Zhu Y; Li H
Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353
[TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
18. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
[TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
20. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
